X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14437) 14437
Book Chapter (56) 56
Dissertation (19) 19
Magazine Article (6) 6
Newspaper Article (5) 5
Conference Proceeding (4) 4
Book / eBook (2) 2
Book Review (2) 2
Government Document (2) 2
Publication (2) 2
Web Resource (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9155) 9155
animals (5904) 5904
signal transduction (3891) 3891
male (3391) 3391
janus kinase 2 (3343) 3343
mice (3326) 3326
female (3229) 3229
janus kinase 2 - genetics (2972) 2972
phosphorylation (2792) 2792
mutation (2692) 2692
hematology (2410) 2410
janus kinase 2 - metabolism (2199) 2199
oncology (2157) 2157
janus kinase (2118) 2118
activation (2094) 2094
biochemistry & molecular biology (1976) 1976
cell biology (1921) 1921
expression (1893) 1893
signal transduction - drug effects (1788) 1788
protein-tyrosine kinases - metabolism (1782) 1782
middle aged (1776) 1776
kinases (1578) 1578
janus kinases - metabolism (1567) 1567
stat3 transcription factor - metabolism (1566) 1566
apoptosis (1551) 1551
adult (1542) 1542
aged (1420) 1420
cytokines (1415) 1415
immunology (1410) 1410
proteins (1386) 1386
cell line, tumor (1325) 1325
cell line (1307) 1307
jak2 (1293) 1293
gene expression (1290) 1290
cells, cultured (1276) 1276
polycythemia-vera (1254) 1254
inflammation (1143) 1143
cancer (1136) 1136
rats (1135) 1135
research (1087) 1087
janus kinase 2 - antagonists & inhibitors (1031) 1031
proto-oncogene proteins (1029) 1029
genetic aspects (1023) 1023
essential thrombocythemia (1012) 1012
stat transcription factors - metabolism (1010) 1010
analysis (1001) 1001
dna-binding proteins - metabolism (996) 996
trans-activators - metabolism (990) 990
transcription (985) 985
signal transduction - physiology (976) 976
myeloproliferative disorders - genetics (962) 962
cells (940) 940
janus kinase 1 (893) 893
stat3 (882) 882
receptor (852) 852
stat3 protein (840) 840
tumors (837) 837
abridged index medicus (836) 836
pharmacology & pharmacy (820) 820
myelofibrosis (808) 808
cell proliferation (794) 794
leukemia (744) 744
gene-expression (743) 743
inhibition (735) 735
aged, 80 and over (726) 726
myeloproliferative neoplasms (724) 724
tyrosine kinase jak2 (716) 716
medicine, research & experimental (700) 700
health aspects (695) 695
myeloproliferative disorders (695) 695
protein kinase inhibitors - pharmacology (695) 695
apoptosis - drug effects (679) 679
research article (668) 668
janus kinases - antagonists & inhibitors (664) 664
mice, inbred c57bl (649) 649
proliferation (643) 643
janus kinase 3 (635) 635
phosphorylation - drug effects (635) 635
multidisciplinary sciences (616) 616
polycythemia vera - genetics (615) 615
protein (611) 611
cell proliferation - drug effects (608) 608
care and treatment (604) 604
signaling (596) 596
janus kinase 1 - metabolism (591) 591
pathway (590) 590
hemic and lymphatic diseases (582) 582
transfection (582) 582
molecular sequence data (580) 580
transcription factors (576) 576
genes (568) 568
protein-tyrosine kinases - genetics (567) 567
blotting, western (565) 565
patients (554) 554
rodents (553) 553
signal-transduction (549) 549
rheumatoid arthritis (547) 547
thrombocythemia, essential - genetics (546) 546
gene (543) 543
medicine (542) 542
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14039) 14039
Chinese (329) 329
Japanese (137) 137
German (51) 51
French (50) 50
Russian (35) 35
Spanish (29) 29
Korean (23) 23
Hungarian (8) 8
Portuguese (7) 7
Danish (6) 6
Polish (5) 5
Dutch (3) 3
Hebrew (3) 3
Turkish (3) 3
Croatian (2) 2
Czech (2) 2
Swedish (2) 2
Finnish (1) 1
Italian (1) 1
Norwegian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International immunopharmacology, ISSN 1567-5769, 2013, Volume 17, Issue 3, pp. 638 - 650
Neutrophils play a critical role in the host defense against bacterial and fungal infections, but their inappropriate activation also contributes to tissue... 
Signaling | Receptors | Inflammation | Kinases | Neutrophils | ACTIVATED PROTEIN-KINASE | COLONY-STIMULATING FACTOR | LEUKOCYTE ADHESION DEFICIENCY | IMMUNOLOGY | SRC-FAMILY KINASES | FORMYL PEPTIDE RECEPTORS | HIGH-AFFINITY RECEPTOR | NOD-LIKE RECEPTORS | BETA-GAMMA-SUBUNIT | TOLL-LIKE RECEPTORS | PHARMACOLOGY & PHARMACY | NF-KAPPA-B | Signal Transduction - immunology | Animals | Receptors, Cell Surface - immunology | Humans | Neutrophils - immunology | Selectins - immunology | Mycoses | Lectins | Fc receptors | Integrins | FcR, Fc-receptor | GPI, glycosylphosphatidylinositol anchor | CLEC, C-type lectin | OSCAR, osteoclast-associated receptor | PKB, protein kinase B | DAG, diacyl-glycerol | Tyk2, tyrosine protein kinase 2 | VCAM-1, vascular cell adhesion molecule 1 | ICAM-1, intercellular adhesion molecule 1 | FADD, Fas-associated protein with death domain | IκB, inhibitor of NF-κB | GM-CSF, granulocyte | MyD88, myeloid differentiation protein 88 | TNF, tumor necrosis factor | LTβ, lymphotoxin β | TRADD, TNFR1-associated death domain protein | Abl, Abelson leukemia proto-oncogene | SLP-76, SH2 domain-containing leukocyte protein of 76 kDa | CALDAG-GEFI, calcium and DAG-regulated guanine nucleotide exchange factor I | IL, interleukin | Src, Rous sarcoma virus proto-oncogene | IRF, IFN regulatory factor | RIG, retinoic acid-inducible gene | PLC, phospholipase C | TCR, T-cell receptor | IKK, IκB kinase | ITAM, immunoreceptor tyrosine-based activation motif | CARD, caspase activation and recruitment domain | IP3, inositol-tris-phosphate | CHO, Chinese hamster ovary cells | MKK, MAP kinase kinase | fMLP, formly-Met-Leu-Phe | TRAF, TNF receptor-associated factor | MIP, macrophage inflammatory protein | Rac, Ras-related C3 botulinum toxin substrate | monocyte colony-stimulating factor | PIP3, phosphatidylinositol-3-phosphate | VLA-4, very late antigen 4 (α4β1 integrin) | PAF, platelet activating factor | STAT, signal transducer and activator of transcription | TAK, TGFβ-activated kinase 1 | Mac-1, macrophage antigen 1 (αMβ2 integrin) | FcRγ, Fc-receptor γ-chain | Asc, apoptosis-associated speck-like protein containing a CARD | cIAP, cellular inhibitor of apoptosis | BCR, B-cell receptor | Fgr, Gardner–Rasheed feline sarcoma proto-oncogene | VASP, vasodilator-stimulated phosphoprotein | Hck, hematopoietic cell kinase | TGFβ, transforming growth factor β | Rap, Ras-related protein | SHP-1, SH2 domain-containing protein tyrosine phosphatase 1 | Syk, spleen tyrosine kinase | GPCR, G protein-coupled receptor | G-CSF, granulocyte colony-stimulating factor | TREM, triggering receptor expressed on myeloid cells | DISC, death-inducing signaling complex | MDL-1, myeloid DAP12-associating lectin 1 | C3G, Crk SH3 domain-binding guanine nucleotide exchange factor (RapGEF1) | NF-κB, nuclear factor κB | ERM, ezrin-radixin-moesin | Epac1, exchange protein activated by cyclic AMP 1 | LTB4, leukotriene B4 | Mcl, macrophage C-type lectin | SAP130, Sin3A-associated protein of 130 kDa | SH2, Src-homology 2 domain | MAP kinase, mitogen-activated protein kinase | PSGL-1, P-selectin glycoprotein ligand | PI3K, phoshoinositide-3-kinase | ADAP, adhesion and degranulation promoting adapter protein (Fyb, SLAP-130) | NLRP3, NOD-like receptor family, pyrin domain containing 3 | MDA5, melanoma differentiation-associated protein 5 | TLR, Toll-like receptor | GRK, GPCR kinase | LAD, leukocyte adhesion deficiency | MAPKAP-kinase, MAP kinase-associated protein kinase | ZAP-70, ζ-chain-associated protein of 70 kDa | TRAIL, TNF-related apoptosis-inducing ligand | JNK, c-Jun N-terminal kinase | LFA-1, lymphocyte function-associated receptor 1 (αLβ2 integrin) | ROS, reactive oxygen species | RIP3, receptor-interacting serine-threonine protein kinase 3 | DAP12, DNAX activating protein 12 | IFN, interferon | PIR, paired immunoglobulin-like receptor | PKC, protein kinase C | PAK, p21-activated kinase | ESL-1, E-selectin ligand 1 | GAP, GTPase activating protein | ERK, extracellular signal-regulated kinase | SOCS, suppressor of cytokine signaling | JAK, Janus kinase | RANK, receptor activator of NF-κB | IRAK, IL-1 receptor-associated kinase | NOD, nucleotide-binding oligomerization domain containing protein | CEACAM3, carcinoembryonic antigen-related cell adhesion molecule 3 (CD66b)
Journal Article
Nature (London), ISSN 1476-4687, 2012, Volume 489, Issue 7414, pp. 155 - 159
...) in most patients with myeloproliferative neoplasm (MPN) led to the clinical development of JAK2 kinase inhibitors(6,7... 
MYELOFIBROSIS | LUNG-CANCER | POLYCYTHEMIA-VERA | GEFITINIB | MYELOPROLIFERATIVE DISORDERS | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | BCR-ABL | MUTATION | RESISTANCE | CHRONIC MYELOID-LEUKEMIA | Myeloproliferative Disorders - enzymology | Phosphorylation | Protein Biosynthesis | Humans | Protein Multimerization | STAT Transcription Factors - metabolism | TYK2 Kinase - metabolism | Janus Kinase 1 - deficiency | TYK2 Kinase - deficiency | Myeloproliferative Disorders - pathology | Janus Kinase 1 - biosynthesis | Gene Knockdown Techniques | Janus Kinase 2 - deficiency | Janus Kinase 1 - metabolism | Granulocytes - drug effects | RNA Interference | Janus Kinase 1 - genetics | Janus Kinase 2 - metabolism | Myeloproliferative Disorders - metabolism | Granulocytes - metabolism | Janus Kinase 2 - antagonists & inhibitors | Disease Models, Animal | Cell Line | Janus Kinase 2 - genetics | Myeloproliferative Disorders - drug therapy | Enzyme Activation - drug effects | TYK2 Kinase - biosynthesis | Granulocytes - enzymology | Animals | Signal Transduction - drug effects | HSP90 Heat-Shock Proteins - antagonists & inhibitors | HSP90 Heat-Shock Proteins - metabolism | Mice | TYK2 Kinase - genetics | Drug Resistance, Neoplasm - drug effects | Enzyme inhibitors | Gene mutations | Cancer cells | Dosage and administration | Genetic aspects | Cellular signal transduction | Identification and classification | Physiological aspects | Care and treatment | Research | Myeloproliferative disorders | Cancer | tyrosine kinase inhibitors | persistence | MPN | JAK2 | resistance
Journal Article
Immunology, ISSN 0019-2805, 04/2015, Volume 144, Issue 4, pp. 561 - 573
.... Our study identified hyperactivated mitogen‐activated protein kinase kinase (MEK)/extracellular signal‐regulated kinase (ERK... 
regulatory T cells | breast cancer | janus kinase/signal transducer and activator of transcription | transforming growth factor‐β | mitogen‐activated protein kinase kinase/extracellular signal‐regulated kinase | nano‐curcumin | Mitogen-activated protein kinase kinase/extracellular signal-regulated kinase | Breast cancer | Regulatory T cells | Janus kinase/signal transducer and activator of transcription | Nano-curcumin | Transforming growth factor-β | FOXP3 EXPRESSION | extracellular signal-regulated kinase | TOLEROGENIC DENDRITIC CELLS | ACTIVATION | TGF-BETA | MECHANISM | janus kinase | CURCUMIN | KAPPA-B | IMMUNOLOGY | signal transducer and activator of transcription | CANCER-THERAPY | MEK/ERK SIGNALING PATHWAY | IN-VIVO | nano-curcumin | mitogen-activated protein kinase kinase | transforming growth factor | Tumor Escape - drug effects | T-Lymphocytes, Regulatory - metabolism | Breast Neoplasms - immunology | Coculture Techniques | Humans | STAT Transcription Factors - metabolism | Tumor Microenvironment | Case-Control Studies | T-Lymphocytes, Regulatory - immunology | Dose-Response Relationship, Drug | Nanoparticles | Breast Neoplasms - enzymology | Time Factors | Forkhead Transcription Factors - metabolism | Female | Tumor Cells, Cultured | MAP Kinase Kinase Kinases - antagonists & inhibitors | MAP Kinase Kinase Kinases - genetics | Curcumin - pharmacology | MAP Kinase Kinase Kinases - metabolism | Breast Neoplasms - drug therapy | Chemistry, Pharmaceutical | T-Lymphocytes, Regulatory - drug effects | Animals | Breast Neoplasms - genetics | Transforming Growth Factor beta - genetics | Interleukin-2 Receptor alpha Subunit - metabolism | Signal Transduction - drug effects | Breast Neoplasms - pathology | Paracrine Communication - drug effects | Mice, Inbred BALB C | Protein Kinase Inhibitors - pharmacology | Antineoplastic Agents, Phytogenic - pharmacology | Smad Proteins - metabolism | Transforming Growth Factor beta - metabolism | transforming growth factor-β | Original
Journal Article
Biochemical journal, ISSN 1470-8728, 2009, Volume 420, Issue 3, pp. 345 - 361
RTKs (receptor tyrosine kinases) play important roles in cellular proliferation and differentiation... 
Extracellular-signal-regulated kinase (ERK) | Pleiotrophin | Anaplastic large cell lymphoma (ALCL) | Neuroblastoma | Non-small cell lung cancer (NSLCL) | Midkine | Anaplastic lymphoma kinase (ALK) | Inflammatory myofibroblastic tumour (IMT) | ALK PROTEIN EXPRESSION | inflammatory myofibroblastic tumour (IMT) | NPM-ALK | HEPARIN-BINDING | GROWTH-FACTOR PLEIOTROPHIN | non-small cell lung cancer (NSLCL) | BIOCHEMISTRY & MOLECULAR BIOLOGY | anaplastic lymphoma kinase (ALK) | EML4-ALK FUSION GENE | neuroblastoma | LARGE-CELL LYMPHOMA | extracellular-signal-regulated kinase (ERK) | pleiotrophin | NEUROTROPHIC FACTOR HBNF | INFLAMMATORY MYOFIBROBLASTIC TUMOR | NON-HODGKINS-LYMPHOMA | midkine | anaplastic large cell lymphoma (ALCL) | RECEPTOR TYROSINE KINASE | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Oncogene Proteins, Fusion - metabolism | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Protein-Tyrosine Kinases - metabolism | Humans | Lung Neoplasms - metabolism | Neuroblastoma - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Lung Neoplasms - pathology | Nuclear Proteins - metabolism | Receptor Protein-Tyrosine Kinases | Protein-Tyrosine Kinases - genetics | Models, Biological | Oncogene Proteins, Fusion - genetics | Lymphoma, Large-Cell, Anaplastic - pathology | Neuroblastoma - metabolism | Nuclear Proteins - genetics | Lymphoma, Large-Cell, Anaplastic - metabolism | Neuroblastoma - pathology | Lymphoma, Large-Cell, Anaplastic - genetics | ALK, anaplastic lymphoma kinase | LTK, leucocyte tyrosine kinase | MUC-1, mucin-1 | IRS-1, IR substrate-1 | PTN, pleiotrophin | TGFβ, transforming growth factor β | ERK, extracellular-signal-regulated kinase | PKB, protein kinase B | Shc, Src homology and collagen homology | TPM, tropomyosin | IMP cyclohydrolase | MK, midkine | MYH9, non-muscle myosin heavy chain | MAM, meprin, A5 protein and receptor protein tyrosine phosphatase mu | NPM, nucleophosmin | mTOR, mammalian target of rapamycin | NIPA, nuclear interacting partner of ALK | RPTP, receptor protein tyrosine phosphatase | DLBCL, diffuse large B-cell lymphoma | FOXO3a, forkhead box O 3a | NF-κB, nuclear factor κB | Shp1, SH2 domain-containing phosphatase 1 | RANBP2, Ran-binding protein 2 | ALCL, anaplastic large cell lymphoma | Dpp, decapentaplegic | FRS2, fibroblast growth factor receptor substrate 2 | LDLa, low-density lipoprotein class A | EGFR, epidermal growth factor receptor | SEC31L1, SEC31 homologue A | GIST, gastrointestinal stromal tumour | RTK, receptor tyrosine kinase | SH2, Src homology 2 | TFG, TRK-fused gene | ATIC, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase | CLTC, clathrin heavy chain | MAPK, mitogen-activated protein kinase | Hen-1, hesitation-1 | MEK, MAPK | PI3K, phosphoinositide 3-kinase | HEK, human embryonic kidney | SCD-2, suppressor of constitutive dauer 2 | Review | EBPβ, CCAAT | CARS, cysteinyl-tRNA synthetase | JNK, c-Jun N-terminal kinase | ERK kinase | Grb2, growthfactor-receptor-bound protein 2 | SCC, squamous cell carcinoma | EML4, echinoderm microtubule-associated protein like 4 | SHH, sonic hedghog | BCR-Abl, breakpoint cluster region-Abl | IR, insulin receptor | ALO17, ALK lymphoma oligomerization partner on chromosome 17 | enhancer-binding protein β | PLCγ, phospholipase Cγ | NSCLC, non-small cell lung cancer | UCN-01, unco-ordinated 1 | Cdc42, cell division cycle 42 | STAT, signal transducer and activator of transcription | DRG, dorsal root ganglia | MSN, moesin | dALK, Drosophila ALK | IL-3, interleukin-3 | CNS, central nervous system | JAK, Janus kinase | CML, chronic myeloid leukaemia | Jeb, jelly belly | IMT, inflammatory myofibroblastic tumour
Journal Article
Journal Article
Journal of clinical immunology, ISSN 1573-2592, 2011, Volume 31, Issue 3, pp. 472 - 478
.... Leptin increased B cells expressing CD25 and HLA-DR. Leptin induces phosphorylation of Janus activation kinase 2 (JAK2... 
Medical Microbiology | Biomedicine | Immunology | Internal Medicine | Infectious Diseases | activation markers | cytokines | B cells | PROTEIN-KINASE | TRANSDUCER | RECEPTOR | PROLIFERATION | IMMUNOLOGY | BLOOD MONONUCLEAR-CELLS | DEFICIENCY | PI3K/AKT | IMMUNE-RESPONSES | T-CELLS | Autoimmunity | Interleukin-6 - analysis | Janus Kinase 2 - biosynthesis | Mitogen-Activated Protein Kinase 3 - analysis | Humans | p38 Mitogen-Activated Protein Kinases - biosynthesis | p38 Mitogen-Activated Protein Kinases - analysis | Dose-Response Relationship, Drug | Signal Transduction - immunology | Inflammation - metabolism | Mitogen-Activated Protein Kinases - analysis | Mitogen-Activated Protein Kinase 3 - biosynthesis | Mitogen-Activated Protein Kinase 6 - analysis | Leptin - pharmacology | Phosphorylation - drug effects | Interleukin-10 - analysis | B-Lymphocytes - metabolism | Janus Kinase 2 - analysis | Enzyme-Linked Immunosorbent Assay | Lymphocyte Activation | Cells, Cultured | Mitogen-Activated Protein Kinases - biosynthesis | Receptors, Leptin - immunology | STAT3 Transcription Factor - analysis | Inflammation - immunology | Tumor Necrosis Factor-alpha - analysis | STAT3 Transcription Factor - biosynthesis | B-Lymphocytes - drug effects | B-Lymphocytes - immunology | Mitogen-Activated Protein Kinase 6 - biosynthesis | Interleukin-6 - biosynthesis | Interleukin-10 - biosynthesis | Receptors, Leptin - metabolism | Tumor Necrosis Factor-alpha - biosynthesis
Journal Article